The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study
Open accessAbstract
Background & Aims Little is known about the heritability of hepatic fibrosis, and the heritability of hepatic steatosis has not been systematically assessed in adults. We investigated the heritability of hepatic fibrosis and steatosis in a community-dwelling twin cohort. Methods We performed a cross-sectional analysis of a cohort of well-characterized twins residing in Southern California including 60 pairs of twins (42 monozygotic and 18 dizygotic; average age, 45.7±22.1 years; average body mass index, 26.4±5.7 kg/m2). We collected data on medical history, physical examinations, fasting laboratory test results, and liver health; all participants underwent an advanced magnetic resonance imaging (MRI) examination of the liver from January 2012 through January 2015. Hepatic steatosis was quantified non-invasively by MRI and determined based on the proton-density fat fraction (MRI-PDFF); liver fibrosis was measured based on stiffness measured by magnetic resonance elastography. Results Twenty-six of the 120 subjects (21.7%) had non-alcoholic fatty liver disease (defined as MRI-PDFF ≥ 5% after exclusion of other causes of hepatic steatosis). The presence of hepatic steatosis correlated between monozygotic twins (r2=0.70, P<.0001) but not between di-zygotic twins (r2=0.36, P=0.2). The level of liver fibrosis also correlated between monozygotic twins (r2=0.48, P<.002) but not between dizygotic twins (r2=.12, P=.7). In multivariable models adjusted for age, sex, and ethnicity, the heritability of hepatic steatosis (based on MRI-PDFF) was 0.52 (95% confidence interval, 0.31–0.73; P<1.1x10−11) and the heritability of hepatic fibrosis (based on liver stiffness) was 0.5 (95% confidence interval, 0.28–0.72; P<6.1 x 10−11). Conclusions A study of twins provides evidence that hepatic steatosis and hepatic fibrosis are heritable traits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287 · cited 1×
“Patients with hepatic fibrosis are at particularly high risk for developing cirrhosis and hepatocellular carcinoma, and require more intense monitoring and therapy.(6,10,11) Underpinning of genetic risk factors associated with hepatic steatosis and fibrosis in NAFLD is one of the top research priorities in the field.”
BackgroundChalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Self-citationLoomba, R., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,641
Self-citationA position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
Yin, M., Talwalkar, J. A., Glaser, K. J., Manduca, A., Grimm, R. C., Rossman, P. J., Fidler, J. L., & Ehman, R. L. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.06.012 · Cited by 948
Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S., & Neuschwander-Tetri, B. A. (2008) · Gut · doi:10.1136/gut.2007.146019 · Cited by 869
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
Reeder, S. B., Cruite, I., Hamilton, G., & Sirlin, C. B. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22580 · Cited by 822
Self-citationMagnetic resonance elastography of liver: Technique, analysis, and clinical applications
Venkatesh, S. K., Yin, M., & Ehman, R. L. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23731 · Cited by 659
Heritability of Mammographic Density, a Risk Factor for Breast Cancer
Boyd, N. F., Dite, G. S., Stone, J., Gunasekara, A., English, D. R., McCredie, M. R. E., Giles, G. G., Tritchler, D., Chiarelli, A., Yaffe, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013390 · Cited by 611
Noureddin, M., Lam, J., Peterson, M. R., Middleton, M., Hamilton, G., Le, T.-A., Bettencourt, R., Changchien, C., Brenner, D. A., Sirlin, C., et al. (2013) · Hepatology · doi:10.1002/hep.26455 · Cited by 550 · cited 1×
“Second, we previously have shown that MRI-PDFF is a more precise marker of liver fat than liver biopsy.(38) Third, emerging data have suggested that MRE stiffness is the most accurate, currently available, noninvasive marker of liver fibrosis.”
BackgroundSelf-citationThe power of the classical twin study
Martin, N. G., Eaves, L. J., Kearsey, M. J., & Davies, P. (1978) · Heredity · doi:10.1038/hdy.1978.10 · Cited by 508
Angulo, P., Bugianesi, E., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Barrera, F., Haflidadottir, S., Day, C. P., & George, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.057 · Cited by 502
Loomba, R., Wolfson, T., Ang, B., Hooker, J., Behling, C., Peterson, M., Valasek, M., Lin, G., Brenner, D., Gamst, A., et al. (2014) · Hepatology · doi:10.1002/hep.27362 · Cited by 489
Self-citationLoomba, R., Abraham, M., Unalp, A., Wilson, L., Lavine, J., Doo, E., & Bass, N. M. (2012) · Hepatology · doi:10.1002/hep.25772 · Cited by 481
Self-citationRotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E., & Liang, J. T. (2010) · Hepatology · doi:10.1002/hep.23759 · Cited by 475
Heritability of Nonalcoholic Fatty Liver Disease
Schwimmer, J. B., Celedon, M. A., Lavine, J. E., Salem, R., Campbell, N., Schork, N. J., Shiehmorteza, M., Yokoo, T., Chavez, A., Middleton, M. S., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.050 · Cited by 466
Self-citationClinical, Laboratory and Histological Associations in Adults with Nonalcoholic Fatty Liver Disease†
Neuschwander-Tetri, B. A., Clark, J. M., Bass, N. M., Van Natta, M. L., Unalp-Arida, A., Tonascia, J., Zein, C. O., Brunt, E. M., Kleiner, D. E., McCullough, A. J., et al. (2010) · Hepatology · doi:10.1002/hep.23784 · Cited by 463
A Population-Based Twin Study of Alcoholism in Women
Kendler, K. S. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490140085040 · Cited by 460
Bhala, N., Angulo, P., van der Poorten, D., Lee, E., Hui, J. M., Saracco, G., Adams, L. A., Charatcharoenwitthaya, P., Topping, J. H., Bugianesi, E., et al. (2011) · Hepatology · doi:10.1002/hep.24491 · Cited by 450
Chen, J., Talwalkar, J. A., Yin, M., Glaser, K. J., Sanderson, S. O., & Ehman, R. L. (2011) · Radiology · doi:10.1148/radiol.11101942 · Cited by 432
Williamson, R. M., Price, J. F., Glancy, S., Perry, E., Nee, L. D., Hayes, P. C., Frier, B. M., Van Look, L. A. F., Johnston, G. I., Reynolds, R. M., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2229 · Cited by 391
Speliotes, E. K., Butler, J. L., Palmer, C. D., Voight, B. F., & Hirschhorn, J. N. (2010) · Hepatology · doi:10.1002/hep.23768 · Cited by 362 · cited 4×
“Underpinning of genetic risk factors associated with hepatic steatosis and fibrosis in NAFLD is one of the top research priorities in the field.(12,13) Hepatic steatosis is a key early event in the development of NAFLD, whereas hepatic fibrosis is a later event that has prognostic significance in predicting long-term…”
BackgroundInfluentialPermutt, Z., Le, T. ‐., Peterson, M. R., Seki, E., Brenner, D. A., Sirlin, C., & Loomba, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05121.x · Cited by 346
Self-citationLoomba, R., Sirlin, C. B., Ang, B., Bettencourt, R., Jain, R., Salotti, J., Soaft, L., Hooker, J., Kono, Y., Bhatt, A., et al. (2015) · Hepatology · doi:10.1002/hep.27647 · Cited by 344
Self-citationNoninvasive evaluation of NAFLD
Castera, L., Vilgrain, V., & Angulo, P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.175 · Cited by 273
Lin, S. C., Heba, E., Wolfson, T., Ang, B., Gamst, A., Han, A., Erdman, J. W., O’Brien, W. D., Andre, M. P., Sirlin, C. B., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.027 · Cited by 254
Self-citationLe, T.-A., Chen, J., Changchien, C., Peterson, M. R., Kono, Y., Patton, H., Cohen, B. L., Brenner, D., Sirlin, C., & Loomba, R. (2012) · Hepatology · doi:10.1002/hep.25731 · Cited by 243
Self-citationAdvanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography
Kim, D., Kim, W. R., Talwalkar, J. A., Kim, H. J., & Ehman, R. L. (2013) · Radiology · doi:10.1148/radiol.13121193 · Cited by 231
Bazick, J., Donithan, M., Neuschwander-Tetri, B. A., Kleiner, D., Brunt, E. M., Wilson, L., Doo, E., Lavine, J., Tonascia, J., & Loomba, R. (2015) · Diabetes Care · doi:10.2337/dc14-1239 · Cited by 206
Self-citationNoureddin, M., Yates, K. P., Vaughn, I. A., Neuschwander-Tetri, B. A., Sanyal, A. J., McCullough, A., Merriman, R., Hameed, B., Doo, E., Kleiner, D. E., et al. (2013) · Hepatology · doi:10.1002/hep.26465 · Cited by 196
Self-citationPatel, N. S., Doycheva, I., Peterson, M. R., Hooker, J., Kisselva, T., Schnabl, B., Seki, E., Sirlin, C. B., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.039 · Cited by 173
Self-citationCui, J. Y., Ang, B., Haufe, W. M., Hernandez, C., Verna, E. C., Sirlin, C. B., & Loomba, R. S. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13196 · Cited by 162
Self-citationMakkonen, J., Pietiläinen, K. H., Rissanen, A., Kaprio, J. A., & Yki‐Järvinen, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.025 · Cited by 156
(2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.001 · Cited by 144
Correlates and Heritability of Nonalcoholic Fatty Liver Disease in a Minority Cohort
Wagenknecht, L. E., Scherzinger, A. L., Stamm, E. R., Hanley, A. J., Norris, J. M., Chen, Y. I., Bryer‐Ash, M., Haffner, S. M., & Rotter, J. I. (2009) · Obesity · doi:10.1038/oby.2009.4 · Cited by 121
Arulanandan, A., Ang, B., Bettencourt, R., Hooker, J. C., Behling, C. A., Lin, G., Valasek, M. A., Ix, J. H., Schnabl, B., Sirlin, C. B., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.01.027 · Cited by 105
Self-citationRole of magnetic resonance elastography in compensated and decompensated liver disease
Asrani, S. K., Talwalkar, J. A., Kamath, P. S., Shah, V. H., Saracino, G., Jennings, L. W., Gross, J. B., Venkatesh, S. K., & Ehman, R. L. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.016 · Cited by 94
Zarrinpar, A., Gupta, S., Maurya, M. R., Subramaniam, S., & Loomba, R. (2016) · Gut · doi:10.1136/gutjnl-2015-309456 · Cited by 88
Self-citationThe Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH
Loomba, R. S., & Chalasani, N. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.016 · Cited by 77
Self-citationControversies in the Diagnosis and Management of NAFLD and NASH.
Rinella, M. E., Loomba, R. S., Caldwell, S. H., Kowdley, K. V., Charlton, M., Tetri, B. A., & Harrison, S. A. (2014) · PubMed · Cited by 74
Self-citationLoomba, R. S., Rao, F., Zhang, L., Khandrika, S., Ziegler, M. G., Brenner, D. A., & O’Connor, D. T. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.009 · Cited by 69
Self-citationHeritability and genetic loci of fatty liver in familial combined hyperlipidemia
Brouwers, M. C. G. J., Cantor, R. M., Kono, N., Yoon, J. L., Kallen, C., Bilderbeek-Beckers, M. A. L., van Greevenbroek, M. M. J., Lusis, A. J., & de Bruin, T. W. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600312-jlr200 · Cited by 66
Tárnoki, Á. D., Tárnoki, D. L., Bata, P., Littvay, L., Osztovits, J., Jermendy, G., Karlinger, K., Lannert, À., Préda, I., Kiss, R. G., et al. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02823.x · Cited by 62
Convergent pathways that cause hepatic fibrosis in NASH
Friedman, S. L. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.256 · Cited by 58
Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis
Reeder, S. B. (2013) · Hepatology · doi:10.1002/hep.26543 · Cited by 53
Tambs, K., Moum, T., Eaves, L., Neale, M., Midthjell, K., Lund-larsen, P., & Naess, S. (1992) · American Journal of Physical Anthropology · doi:10.1002/ajpa.1330880303 · Cited by 51
Weber, S. N., Gressner, O. A., Hall, R. A., Grünhage, F., & Lammert, F. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.012 · Cited by 36
The TM6SF2 Variants, Novel Genetic Predictors for Nonalcoholic Steatohepatitis
Roh, Y., Loomba, R. S., & Seki, E. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.11.014 · Cited by 23
Self-citationGenetic Studies to Identify Hepatic Fibrosis Genes and SNPs in Human Populations
Day, C. P. (2005) · Humana Press eBooks · doi:10.1385/1-59259-940-0:315 · Cited by 14
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Self-citationMechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
“The majority of individuals with NAFLD are asymptomatic, and the disease may remain silent until it has progressed to cirrhosis (Spengler and Loomba, 2015).”
BackgroundSelf-citation
Metadata
- Authors
- Loomba, R., Schork, N., Chen, C.-H., Bettencourt, R., Bhatt, A., Ang, B., Nguyen, P., Hernandez, C., Richards, L., Salotti, J., Lin, S., Seki, E., Nelson, K. E., Sirlin, C. B., & Brenner, D.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 149
- Issue
- 7
- Pages
- 1784-1793
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1614032175
- Cited by
- 389
- References
- 53
- FWCI
- 22.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.